BioAmp is addressing antibiotic resistance, a global health problem. It is estimated that $4.6 B of annual costs to the US healthcare system are attributed to 6 common antibiotic resistant bacterial threats. Infections caused by 1 these antibiotic-resistant bacteria are subject to poorer outcomes because it can take 3-14 days to confirm or rule out their presence, resulting in 4-times higher mortality rates and $65+k per patient costs.